Haemopoietic stem-cell transplantation for systemic sclerosis

Keith M Sullivan; Frederick M Wigley; Christopher P Denton; Jacob M van Laar; Daniel E Furst

doi:10.1016/S0140-6736(12)60100-7

Haemopoietic stem-cell transplantation for systemic sclerosis

Keith M Sullivan, Frederick M Wigley, Christopher P Denton, Jacob M van Laar, Daniel E Furst

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	219; author reply 219-20
Journal	The Lancet
Volume	379
Issue number	9812
DOIs	https://doi.org/10.1016/S0140-6736(12)60100-7
Publication status	Published - 21 Jan 2012

Keywords

Cyclophosphamide
Early Termination of Clinical Trials
Female
Hematopoietic Stem Cell Transplantation
Humans
Immunosuppressive Agents
Male
Scleroderma, Systemic
Comment
Letter

Access to Document

10.1016/S0140-6736(12)60100-7

Cite this

@article{ef2fb63dd086414793c9e6c466606067,

title = "Haemopoietic stem-cell transplantation for systemic sclerosis",

keywords = "Cyclophosphamide, Early Termination of Clinical Trials, Female, Hematopoietic Stem Cell Transplantation, Humans, Immunosuppressive Agents, Male, Scleroderma, Systemic, Comment, Letter",

author = "Sullivan, {Keith M} and Wigley, {Frederick M} and Denton, {Christopher P} and {van Laar}, {Jacob M} and Furst, {Daniel E}",

year = "2012",

month = jan,

day = "21",

doi = "10.1016/S0140-6736(12)60100-7",

language = "English",

volume = "379",

pages = "219; author reply 219--20",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "9812",

}

TY - JOUR

T1 - Haemopoietic stem-cell transplantation for systemic sclerosis

AU - Sullivan, Keith M

AU - Wigley, Frederick M

AU - Denton, Christopher P

AU - van Laar, Jacob M

AU - Furst, Daniel E

PY - 2012/1/21

Y1 - 2012/1/21

KW - Cyclophosphamide

KW - Early Termination of Clinical Trials

KW - Female

KW - Hematopoietic Stem Cell Transplantation

KW - Humans

KW - Immunosuppressive Agents

KW - Male

KW - Scleroderma, Systemic

KW - Comment

KW - Letter

U2 - 10.1016/S0140-6736(12)60100-7

DO - 10.1016/S0140-6736(12)60100-7

M3 - Article

C2 - 22265628

SN - 0140-6736

VL - 379

SP - 219; author reply 219-20

JO - The Lancet

JF - The Lancet

IS - 9812

ER -